Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis.

摘要: A combination of multiple agents is often required to achieve treatment success for plaque-type psoriasis. We report a case series 10 patients that were treated with betamethasone valerate foam (0.12%) in the morning and topical tazarotene cream (0.1%) evening total 12 weeks or until plaques cleared. Erythema, scale, thickness along an aggregate severity score determined at 4, 8, 12. One patient was lost follow-up. Eight other 9 experienced improvement their disease by week Two clear psoriasis 4 8. No adverse events, including irritation reported; use corticosteroid may protect against potential local reported tazarotene. The effective approach treating localized